Surgery versus SABR for early-stage lung cancer-time to call it a draw?

Lancet Oncol. 2021 Oct;22(10):1355-1357. doi: 10.1016/S1470-2045(21)00457-5. Epub 2021 Sep 13.

Authors

Alexander V Louie¹, Michael C Tjong², Shankar Siva³

Affiliations

¹ Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M5M 2W9, Canada. Electronic address: alexander.louie@sunnybrook.ca.
² Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M5M 2W9, Canada.
³ Department of Radiation Oncology, Peter MacCallum Cancer Centre, University of Melbourne, VIC, Australia.

PMID: 34529929
DOI: 10.1016/S1470-2045(21)00457-5

No abstract available

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*